Several reports maintain this detrimental role of microglia in stroke; however, these reports are not consistent with their markers, often looking broadly at Iba1+ or CD11b+ cells, and sometimes using glial fibrillary acidic protein (GFAP), a marker often used to label reactive astrocytes to identify microglia. Here, GFAP is linked to stroke disorder.